Eam Investors, LLC Silverback Therapeutics, Inc. Transaction History

Eam Investors, LLC

  • $569 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Jul 12, 2023
BUY
N/A
52,809 Added 528.67%
62,798 $0
Q1 2023

May 12, 2023
SELL
N/A
-114,784 Reduced 91.99%
9,989 $0
Q4 2022

Feb 14, 2023
BUY
$0.0 - $6.07 $0 - $757,372
124,773 New
124,773 $0

Others Institutions Holding SBTX

# of Institutions
117
Shares Held
47.9M
Call Options Held
442K
Put Options Held
42K
View Full List

About Silverback Therapeutics, Inc.

SBTX Quotes by TradingView
  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email